doi: 10.1016/j.biopha.2019.108667 10 LeeMMYPetrieMCMcMurrayJJVSattarN
A recent systematic review of GLP-1 agonist exposure found that animal studies showed risks such as fetal growth restriction and skeletal abnormalities, and due to limited human data, experts recommend stopping these medications in both pregnancy and during breastfeeding
Pros Fully licensed and publicly traded, providing a layer of accountability Wide range of treatment categories beyond just weight loss Fast, convenient process for straightforward prescriptions Competitive pricing on many products, especially generics Discreet packaging and home delivery Available in all 50 states Cons Asynchronous consultations may feel impersonal, especially for complex treatments GLP-1 program relies on compounded medications, not brand-name drugs Limited provider continuity
This product should not be used as a substitute for a varied and balanced diet and healthy lifestyle
Eating bland foods, staying hydrated, and avoiding large meals around injection time helps prevent it
Tests for heterogeneity within designs were not significant (Q = 2.29, df = 10, p = 0.994), indicating consistency among the study results
